146 related articles for article (PubMed ID: 28916184)
1. Role of the IL-12/IL-35 balance in patients with Sjögren syndrome.
Fogel O; Rivière E; Seror R; Nocturne G; Boudaoud S; Ly B; Gottenberg JE; Le Guern V; Dubost JJ; Nititham J; Taylor KE; Chanson P; Dieudé P; Criswell LA; Jagla B; Thai A; Mingueneau M; Mariette X; Miceli-Richard C
J Allergy Clin Immunol; 2018 Jul; 142(1):258-268.e5. PubMed ID: 28916184
[TBL] [Abstract][Full Text] [Related]
2. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
5. Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.
Lester S; Stokes L; Skarratt KK; Gu BJ; Sivils KL; Lessard CJ; Wiley JS; Rischmueller M
Arthritis Res Ther; 2013 Jun; 15(4):R71. PubMed ID: 23819992
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
7. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
Zheng L; Yu C; Zhang Z; Yang C; Cai X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
[TBL] [Abstract][Full Text] [Related]
8. Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndrome.
Soto-Cárdenas MJ; Gandía M; Brito-Zerón P; Arias MT; Armiger N; Bové A; Bosch X; Retamozo S; Akasbi M; Pérez-De-Lis M; Gueitasi H; Kostov B; Pérez-Alvarez R; Siso-Almirall A; Lozano F; Ramos-Casals M
J Rheumatol; 2015 Jan; 42(1):111-8. PubMed ID: 25362659
[TBL] [Abstract][Full Text] [Related]
9. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
10. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.
Petrek M; Cermáková Z; Hutyrová B; Miceková D; Drábek J; Rovensky J; Bosák V
Clin Exp Rheumatol; 2002; 20(5):701-3. PubMed ID: 12412204
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.
Hargreaves P; Daoudlarian D; Theron M; Kolb FA; Manchester Young M; Reis B; Tiaden A; Bannert B; Kyburz D; Manigold T
Arthritis Res Ther; 2019 Jul; 21(1):175. PubMed ID: 31319889
[TBL] [Abstract][Full Text] [Related]
12. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
[TBL] [Abstract][Full Text] [Related]
13. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
15. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2001 Jun; 40(6):656-61. PubMed ID: 11426023
[TBL] [Abstract][Full Text] [Related]
16. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
[TBL] [Abstract][Full Text] [Related]
17. Expression of G
Sun Y; Wang Y; Chen S; Fan G; Zhang J; Dai F; Qian H; Liu Y; Shi G
J Immunol Res; 2018; 2018():8212641. PubMed ID: 29977933
[TBL] [Abstract][Full Text] [Related]
18. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
19. A pathogenetic role for IL-21 in primary Sjögren syndrome.
Kwok SK; Lee J; Yu D; Kang KY; Cho ML; Kim HR; Ju JH; Lee SH; Park SH; Kim HY
Nat Rev Rheumatol; 2015 Jun; 11(6):368-74. PubMed ID: 25584898
[TBL] [Abstract][Full Text] [Related]
20. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
